Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Aldose reductase: A novel therapeutic target for inflammatory pathologies
Kota V. Ramana
, Satish K. Srivastava
Research output
:
Contribution to journal
›
Short survey
›
peer-review
167
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aldose reductase: A novel therapeutic target for inflammatory pathologies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aldehydes
33%
Aldose Reductase
100%
Aldose Reductase Inhibitor
66%
Anti-inflammatory Drugs
33%
Asthma
33%
Breast
33%
Cancer Disease
33%
Cardiovascular Disease
33%
Catalytic Activity
33%
Clinical Trials
33%
Colon
33%
Colon Cancer
33%
Diabetes Complications
66%
Glucose Metabolism
33%
Glutathione Conjugates
33%
Health Anxiety
33%
Human Cancer
33%
Inflammatory Diseases
33%
Inflammatory Pathologies
100%
Lipid Peroxidation
33%
Liver
33%
Novel Therapeutic Targets
100%
Polyol Pathway
33%
Rate-limiting Step
33%
Sepsis
33%
Sorbitol
33%
Uveitis
33%
Medicine and Dentistry
Aldehyde
33%
Aldehyde Reductase
100%
Aldose Reductase Inhibitor
66%
Antiinflammatory Agent
33%
Asthma
33%
Atherosclerosis
33%
Cancer
33%
Cardiovascular Disease
33%
Clinical Trial
33%
Colon
33%
Colon Carcinoma
33%
Complications of Diabetes Mellitus
66%
Glucose Metabolism
33%
Glutathione
33%
Inflammatory Disorder
33%
Lipid Peroxidation
33%
Malignant Neoplasm
33%
Polyol Pathway
33%
Sepsis
33%
Sorbitol
33%
Uveitis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Aldehyde
33%
Aldehyde Reductase
100%
Aldose Reductase Inhibitor
66%
Antiinflammatory Agent
33%
Asthma
33%
Atherosclerosis
33%
Cardiovascular Disease
33%
Clinical Trial
33%
Colon Carcinoma
33%
Diabetic Complication
66%
Glutathione
33%
Inflammatory Disease
33%
Malignant Neoplasm
33%
Polyol
33%
Sepsis
33%
Sorbitol
33%
Uveitis
33%
Biochemistry, Genetics and Molecular Biology
Aldose Reductase
100%
Aldose Reductase Inhibitor
66%
Anti-Inflammatory
33%
Clinical Trial
33%
Colon
66%
Enzymatic Activity
33%
Glucose Metabolism
33%
Glutathione
33%
Lipid Peroxidation
33%
Polyol Pathway
33%
Sorbitol
33%